Actively Recruiting
The Impact of Radiotherapy on Oligometastatic Cancer
Led by Institut Investigacio Sanitaria Pere Virgili · Updated on 2024-11-18
2000
Participants Needed
21
Research Sites
787 weeks
Total Duration
On this page
Sponsors
I
Institut Investigacio Sanitaria Pere Virgili
Lead Sponsor
H
Hospital Ruber Internacional
Collaborating Sponsor
AI-Summary
What this Trial Is About
Metastases represent the most threatening challenge in cancer. One of the management strategies for patients with Oligometastatic Cancer (OC) is Stereotactic ABlative Radiotherapy (SABR). However, there are few studies, and there is no defined clinical standard, nor are the radiobiological mechanisms that contribute to treatment response well understood. The focus should be on generating evidence to guide the personalization of radiotherapy beyond solely technological and anatomical precision. This could be achieved by recollecting clinical and biological data from patients that undergo this treatment and analyzing them to ultimately predict, with the help of artificial intelligence, which patients will be the most beneficiary and improve their survival rate.
CONDITIONS
Official Title
The Impact of Radiotherapy on Oligometastatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologic confirmation of primary tumor: breast, prostate, lung, colorectal.
- 18 years old or older.
- Up to five metastases located in the bone, lung, node, liver or brain.
- Eastern Cooperative Oncology Group (ECOG) Performance Status Scale 0 or 1.
You will not qualify if you...
- Non-melanoma skin cancer.
- Previous radiotherapy in the same anatomic location.
- Presence of vascular collagen disease.
- Pregnancy or lactation at the time of inclusion.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 21 locations
1
Complejo Hospitalario Universitario Albacete
Albacete, Albacete, Spain
Not Yet Recruiting
2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
Not Yet Recruiting
3
Hospital Universitari Vall d'Hebron
Barcelona, Barcelona, Spain
Not Yet Recruiting
4
Institut Català d'Oncologia
Barcelona, Barcelona, Spain
Not Yet Recruiting
5
Hospital Universitario Virgen de las Nieves
Granada, Granada, Spain
Not Yet Recruiting
6
Hospital Universitari Arnau de Vilanova
Lleida, Lleida, Spain
Not Yet Recruiting
7
Hospital de La Luz
Madrid, Madrid, Spain
Not Yet Recruiting
8
Hospital Ruber Internacional
Madrid, Madrid, Spain
Not Yet Recruiting
9
Hospital Universitario HM Sanchinarro
Madrid, Madrid, Spain
Not Yet Recruiting
10
Hospital Universitario Quirónsalud
Madrid, Madrid, Spain
Not Yet Recruiting
11
Hospital Universitario Rey Juan Carlos
Madrid, Madrid, Spain
Not Yet Recruiting
12
Hospital Universitario Virgen Macarena
Seville, Sevilla, Spain
Not Yet Recruiting
13
Hospital Universitari Sant Joan de Reus
Reus, Tarragona, Spain, 43204
Actively Recruiting
14
Hospital Clínico Universitario de Valencia
Valencia, Valencia, Spain
Not Yet Recruiting
15
Hospital General Univesitario de Valencia
Valencia, Valencia, Spain
Not Yet Recruiting
16
Hospital Universitari Miguel Servet
Zaragoza, Zaragoza, Spain
Not Yet Recruiting
17
Hospital del Mar
Barcelona, Spain
Not Yet Recruiting
18
Hospital Provincial de Castellón
Castellon, Spain
Not Yet Recruiting
19
Institut Català d'Oncologia
Girona, Spain
Not Yet Recruiting
20
Hospital Universitario Ramón y Cajal
Madrid, Spain
Not Yet Recruiting
21
Hospital de Terrassa
Terrassa, Spain
Not Yet Recruiting
Research Team
J
Jorge Joven, Prof.
CONTACT
M
Meritxell Arenas, PhD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here